Cystic Fibrosis Foundation - Click here for homepage
Stay Informed  |  Volunteer  |  Clinical Trials

In This Section

Quick Links

Find a Chapter

Get Assistance

Get Assistance - Cox Boys
We are here to help people with CF get the insurance coverage they need. Hear how the Foundation helped the Cox family.

Join us on Facebook!  Facebook 
Follow us on Twitter!   Twitter
Follow us on Instagram!  Instagram 
Add us to your circle in Google+!

Google+ 

Subscribe to our channel on YouTube!  YouTube  


 

 

Print  

FDA Issues Response Letter for Liprotamase

April 19, 2011

Eli Lilly and Company has received a complete response letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for liprotamase, a non-porcine pancreatic enzyme replacement therapy (PERT), under investigation for the treatment of exocrine pancreatic insufficiency.
 
The complete response letter communicated the need for Lilly to conduct an additional clinical trial prior to a re-submission.
 
The CF Foundation will continue to work with Eli Lilly and the FDA as liprotamase moves through the FDA review and approval process.
 
Read more in the news release from Eli Lilly.

The Cystic Fibrosis Foundation is an accredited charity of the Better Business Bureau.